(Q40624035)
Statements
1 reference
A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (English)
1 reference
Ganly I
1 reference
Kirn D
1 reference
Eckhardt G
1 reference
Rodriguez GI
1 reference
Soutar DS
1 reference
Otto R
1 reference
Robertson AG
1 reference
Park O
1 reference
Gulley ML
1 reference
Heise C
1 reference
Von Hoff DD
1 reference
Kaye SB
1 reference
1 March 2000
1 reference
1 reference